The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 84 of 7573
Back to Result List

Silent neonatal influenza A virus infection primes systemic antimicrobial immunity

Please always quote using this URN: urn:nbn:de:bvb:20-opus-304782
  • Infections with influenza A viruses (IAV) cause seasonal epidemics and global pandemics. The majority of these infections remain asymptomatic, especially among children below five years of age. Importantly, this is a time, when immunological imprinting takes place. Whether early-life infections with IAV affect the development of antimicrobial immunity is unknown. Using a preclinical mouse model, we demonstrate here that silent neonatal influenza infections have a remote beneficial impact on the later control of systemic juvenile-onset andInfections with influenza A viruses (IAV) cause seasonal epidemics and global pandemics. The majority of these infections remain asymptomatic, especially among children below five years of age. Importantly, this is a time, when immunological imprinting takes place. Whether early-life infections with IAV affect the development of antimicrobial immunity is unknown. Using a preclinical mouse model, we demonstrate here that silent neonatal influenza infections have a remote beneficial impact on the later control of systemic juvenile-onset and adult-onset infections with an unrelated pathogen, Staphylococcus aureus, due to improved pathogen clearance and clinical resolution. Strategic vaccination with a live attenuated IAV vaccine elicited a similar protection phenotype. Mechanistically, the IAV priming effect primarily targets antimicrobial functions of the developing innate immune system including increased antimicrobial plasma activity and enhanced phagocyte functions and antigen-presenting properties at mucosal sites. Our results suggest a long-term benefit from an exposure to IAV during the neonatal phase, which might be exploited by strategic vaccination against influenza early in life to enforce the host’s resistance to later bacterial infections.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Anna Sophie Heinemann, Jan Lennart Stalp, João Pedro Pereira Bonifacio, Filo Silva, Maike Willers, Julia Heckmann, Beate Fehlhaber, Lena Völlger, Dina Raafat, Nicole Normann, Andreas Klos, Gesine Hansen, Mirco Schmolke, Dorothee Viemann
URN:urn:nbn:de:bvb:20-opus-304782
Document Type:Journal article
Faculties:Medizinische Fakultät / Kinderklinik und Poliklinik
Language:English
Parent Title (English):Frontiers in Immunology
Year of Completion:2023
Volume:14
Article Number:1072142
Source:Frontiers in Immunology (2023) 14:1072142. https://doi.org/10.3389/fimmu.2023.1072142
DOI:https://doi.org/10.3389/fimmu.2023.1072142
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:Staphylococcus aureus; antimicrobial immunity; influenza A virus; influenza vaccination; innate immunity training; neonate; sepsis
Release Date:2024/05/31
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International